Article info

Download PDFPDF
Letter
The ARSACS phenotype can include supranuclear gaze palsy and skin lipofuscin deposits

Authors

  • James C Stevens MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UKDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Sinéad M Murphy Department of Neurology, The Adelaide and Meath Hospital Dublin, Incorporating the National Children's Hospital, Tallaght, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Indran Davagnanam Department of Neuroradiology, National Hospital for Neurology and Neurosurgery and Institute of Neurology, London, UKDepartment of Brain Repair and Rehabilitation, National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Rahul Phadke Department of Neuropathology, The National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Glenn Anderson Department of Neuropathology, The National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Suran Nethisinghe MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UKDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Fion Bremner Department of Neuro-ophthalmology, The National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Paola Giunti MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UKDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Mary M Reilly MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UKDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James Stevens, Consultant Neurologist, North Bristol NHS Trust, Frenchay Hospital, Bristol BS16 7DT, UK; james.stevens{at}nbt.nhs.uk
View Full Text

Citation

Stevens JC, Murphy SM, Davagnanam I, et al
The ARSACS phenotype can include supranuclear gaze palsy and skin lipofuscin deposits

Publication history

  • Received July 13, 2012
  • Revised September 24, 2012
  • Accepted September 26, 2012
  • First published November 3, 2012.
Online issue publication 
December 13, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.